Delivery Order SPE2DB20D1109-SPE2DB24FN03A
Award Date
11/6/23
Potential Completion Date
11/7/23
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRBJ7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,523.20 delivery order is for the supply of the pharmaceutical product NAROPIN 0.5% 150 MG/30 ML VIAL 30ML. The contract has a firm fixed price and an ultimate completion date of February 13, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product, and has a ceiling value of $1,352.72. The contract is a firm fixed price delivery order with an ultimate completion date of April 2, 2024. This award is associated...
The U.S. Defense Logistics Agency (DLA) awarded a $1,899.09 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564717803 - NAROPIN 0.5% 150 MG/30 ML VIAL 30ML. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies...
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,599.42, is for the delivery of NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement. The contract has an ultimate completion date of November 20, 2023 and was awarded on November 17, 2023. This award...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,627.60 and is for the delivery of the drug NAROPIN 0.5% 100 MG/20 ML VIAL 20ML. The contract is a firm-fixed price, delivery order type and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Naropin 0.5% 150 mg/30 ml vials to the Defense Logistics Agency (DLA), a defense agency. The $2,331.68 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 13, 2024, with a completion date of December 16, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564184299 - NAROPIN 0.5% 150 MG/30 ML VIAL 30ML. The $5,266.26 contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,291.53 firm fixed-price delivery order is for the supply of NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a medical product. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563539837 NAROPIN 0.5% 100 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $5,221.35. The contract is a firm fixed-price delivery order that runs through February 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of a pharmaceutical product, NAROPIN 0.5% 150 MG/30 ML VIAL 30ML, at a firm fixed price of $1,558.98. The contract has a completion date of February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside...